Fingerprint
Dive into the research topics of 'Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers
David H. Peng, B. Leticia Rodriguez, Lixia Diao, Pierre Olivier Gaudreau, Aparna Padhye, Jessica M. Konen, Joshua K. Ochieng, Caleb A. Class, Jared J. Fradette, Laura Gibson, Limo Chen, Jing Wang, Lauren A. Byers, Don L. Gibbons
Research output: Contribution to journal › Article › peer-review
39
Scopus
citations